Imvax has shrugged off the failure of its phase 2b brain cancer trial to hit its primary endpoint, reporting evidence of improved overall survival (OS) and making a beeline for the FDA. The study ...

On Friday, Johnson & Johnson (NYSE: JNJ) said that the Phase 2b AuTonomy proof-of-concept study of posdinemab did not achieve statistical significance in slowing clinical decline in patients with ...

ILiAD Biotechnologies, LLC (ILiAD), an advanced clinical stage biotech company focused on the prevention and treatment of disease caused by Bordetella Pertussis, today announced the peer-reviewed ...

Coeur Mining is rated 'Buy' due to a compelling risk-reward setup driven by operational inflection and the New Gold acquisition. CDE's Q3 showed 77% revenue growth, roughly $2 million daily free cash ...

Australian gold producer Perseus Mining (OTCPK:PMNXF) said late Tuesday that it made a binding offer to acquire Predictive Discovery (OTCPK:PDIYF) valued at more than A$2.0 billion, equivalent to US$1 ...

JPMorgan analysts Reginald Smith and Charles Pearce said miners are entering a "higher-conviction" phase of high-power compute transitions as more than 600 megawatts of long-term AI-related deals were ...

The Government will kill off any prospect of HS2 getting to Crewe by allowing parliamentary powers to expire within weeks, The i Paper understands. Rishi Sunak axed the northern leg of the high-speed ...

A new year means a new Fierce Biotech Fundraising Tracker to record the significant amounts of venture capital being funneled into the industry. We're maintaining the criteria we used for last year's ...